Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction

IMPORTANCE: There is growing recognition that patients may respond differently to therapy and that the average treatment effect from a clinical trial may not apply equally to all candidates for a therapy. OBJECTIVE: To determine whether, among patients with an ischemic stroke or transient ischemic a...

詳細記述

保存先:
書誌詳細
出版年:JAMA Neurol
主要な著者: Kernan, Walter N., Viscoli, Catherine M., Dearborn, Jennifer L., Kent, David M., Conwit, Robin, Fayad, Pierre, Furie, Karen L., Gorman, Mark, Guarino, Peter D., Inzucchi, Silvio E., Stuart, Amber, Young, Lawrence H.
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2017
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710663/
https://ncbi.nlm.nih.gov/pubmed/28975241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2017.2136
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料